|
Technologies
map: Guide to terms in these
glossaries Site Map
Related glossaries include Applications: Drug
discovery & development Functional
genomics, Genomics, Metabolic
engineering, Phylogenomics Proteomics
Informatics: Bioinformatics, Cheminformatics
Technologies: Bioprocessing Gene amplification
& PCR Microarrays
Biology: Cell biology, Gene
definitions, Pharmaceutical
biology, Proteins, RNA
SNPs & other genetic variations
animal models: Functional
genomics
antibody
display: de Kruif
J,, Boel E, Logtenberg T. Selection
and application of human single chain Fv antibody fragments from a
semi-synthetic phage antibody display library with designed CDR3 regions.
J Mol Biol. 1995 Apr 21;248 (1): 97-105, April 1995 .
Google = about 17,200
Nov 13, 2006
antisense: Pharmaceutical
biology
aptamer:
Oligonucleotide
which displays specific binding to a protein or other target,
often selected by an iterative cycle of affinity- based enrichment.
Narrower term:
Functional
genomics peptide aptamer Related term: SELEX. [IUPAC
Combinatorial Chemistry]
BAC: See Bacterial Artificial Chromosome.
Bacterial artificial chromosome (BAC):
A vector used to clone
DNA fragments (100- to 300-kb insert size; average, 150 kb) in Escherichia
coli cells. Based on naturally occurring F-factor plasmid found in
the bacterium E. coli. Compare cloning vector. [DOE]
DNA constructs that are composed of, at least, a REPLICATION ORIGIN, for successful replication, propagation to and
maintenance as an extra chromosome in bacteria. In addition, they can carry large amounts (about 200
kilobases) of other sequence for a variety of bioengineering purposes.
MeSH, 2002
Related
term: BAC maps. Maps, genetic & genomic
bacteriophage:
Many phage have proved useful in the study of
molecular biology and as vectors for the transfer of genetic information
between cells … lambda bacteriophage can also undergo a lytic cycle or
can enter a lysogenic cycle, in which the page DNA is incorporated into
that of the host, awaiting a signal that initiates events leading to replication
of the virus and lysis of the host cell. [Glick]
The workhorse of phage display is the M13 bacteriophage virus.
Related terms: phage,
phage display bacteriophage, biopanning, phage; Labels, signaling & detection
Proteomics directed protein evolution
biochemical genomics: Chemistry
& biology
biotechnology: The integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof
and molecular analogues for products and services.
[IUPAC Compendium]
It
is important to understand the distinction between biotechnology as a new
process technology and as a drug discovery research tool. The first
uses genetic engineering to manufacture large molecular weight drugs that cannot
be directly synthesized or extracted. The second involves understanding the
molecular basis of disease and the search for new therapeutic targets
using techniques such as cloned receptors as screens or transgenic organisms
created through gene knock-out technologies to determine protein function; most
of the focus is on small molecule drugs that interact against those targets. As
the pharmaceutical industry is using biotechnology in drug discovery, it will
likely maintain its dominant position in small molecules, but the development
and manufacture of protein based therapeutics requires a completely different
set of core competencies. Product Definition, The Biopharmaceutical Sector,
Industry Canada, 2003 http://strategis.ic.gc.ca/epic/internet/inbio-pha.nsf/en/df00020e.html#2.1
Related
terms: Business of biotechnology biotechnology
firms, biotechnology industry
biopharmaceuticals: Drug
approvals biotechnology drugs: Drug
approvals
BioTech blog http://biotechblog.com/
Articles from Signals (Recombinant Capital), Mass High Tech, Wired medtech, New
Scientist, Boston Globe and others.
Corante:
Biotechnology http://www.corante.com/biotech/
Corante: In the Pipeline http://www.corante.com/pipeline/
SimpleTrend:
BioTech http://startsimple.com/trend/biotech/index.html
Related term: Business
of biopharmaceuticals biotechnology industry
cDNA phage display:
Display
cloning: functional identification of natural product receptors using cDNA-phage
display. Sche PP, McKenzie KM, White JD, Austin DJ. Chem Biol. 1999
Oct;6(10):707- 716
Google =
about 537 Nov 13, 2006
chemical genetics, chemical genomics, chemogenomics: Dr
Chemistry & biology
chemical mutagenesis:
Systematic mutagenesis using chemical with
mutagenic properties.
chemical
proteomics: Chemistry & biology
clone:
A population of genetically identical cells produced from
a common ancestor. Sometimes also used to refer to a number of recombinant
DNA molecules all carrying the same inserted sequence. [IUPAC Medicinal
Chemistry, IUPAC Compendium]
Clone was coined by Herbert J. Webber in 1903 for "a colony of organisms
derived asexually from a single progenitor" and was quickly adopted by
botanists and cell biologists. But the popular perception of cloning can be
traced to Alvin Toffler's Future Shock (1970) and was quickly popularized
(and extended to items such as computers). But Lee Silver, Professor of
Molecular Biology and Public Affairs, Princeton Univ. concludes that "the
scientific community has lost control over Webber's pleasant sounding little
word. Cloning has a popular connotation that is impossible to dislodge. We must
accept that democratic debate on cloning is bereft of any meaning. Science and
Scientists would be better served by choosing other words to explain advances in
developmental biotechnology to the public". [L. Silver "What are
clones? They're not what you think they are" Nature 412 (6842): 21, 5 July
2001]
Narrower term: clone bank
clone bank:
Genomic library, a collection of clones made from
a set of randomly generated overlapping DNA fragments representing the
entire genome of an organism. [Schlindwein]
Related term: genomic library
cloning: Using specialized DNA technology (see cloning vector)
to produce multiple, exact copies of a single gene or
other segment of DNA to obtain enough material for further study. This
process is used by researchers in the Human Genome Project, and is referred
to as cloning DNA. The resulting cloned (copied) collections of
DNA molecules are called clone libraries. A second type of cloning exploits
the natural process of cell division to make many copies of an entire cell.
The genetic makeup of these cloned cells, called a cell line, is
identical to the original cell. A third type of cloning produces complete,
genetically identical animals such as the famous Scottish sheep,
Dolly. [DOE]
The process of making copies of a specific piece of DNA, usually a gene.
When geneticists speak of cloning, they do not mean the process of making
genetically identical copies of an entire organism. [NHGRI]
Cloning, US President's Council on Bioethics
http://www.bioethics.gov/topics/cloning_index.html
Cloning & nuclear transfer: A short glossary, Mike
McKeen, Roslin Institute Online, Scotland, 1999
http://www.ri.bbsrc.ac.uk/library/research/cloning/glossary.html#clon
Cloning and nuclear transfer: moral and ethical concerns, Harry
Griffin, Ian Wilmut, Grahame Bulfield, Roslin Institute, Scotland, 1998
http://www.ri.bbsrc.ac.uk/library/research/cloning/nt-ethics.html
Dolly the sheep, Nature http://www.nature.com/nature/dolly/
Of course many plants can be cloned (cuttings). And identical twins are (in a
technical sense) clones, who can be organ donors for each other without
immunosuppressants
Related terms: enucleated, directed evolution,
molecular evolution, nuclear transfer, quiescence; Narrower terms:
cloning vector:
DNA molecule originating from a virus, a plasmid,
or the cell of a higher organism into which another DNA fragment of appropriate
size can be integrated without loss of the vectors capacity for self replication;
vectors introduce foreign DNA into host cells, where it can be reproduced
in large quantities. Examples are plasmids, cosmids, and yeast artificial
chromosomes [YACs]; vectors are often recombinant molecules containing
DNA sequences from several sources. [DOE]
comparative genomics: Functional
genomics comparative
systems biology: My research projects in comparative
systems biology have four main thrusts: whole-genome functional
annotation, multi-clustering of molecular profiles, cross-condition analysis
of functional genomics data, and computationally-driven design of biological
experiments. The research I am conducting with my life science colleagues in
comparative systems biology has the goal of providing precise functional
annotations to hypothetical genes in model organisms and in newly-sequenced
genomes; delineating similarities and differences in cellular networks
activated in different diseases; identifying core cellular pathways common to
response networks for multiple stresses in various model organisms; and
refining our understanding of the molecular basis of disease resistance in
plant-pathogen interactions. Research interests, TM Murali, Computer Sciences,
Virginia Tech, http://people.cs.vt.edu/~murali/research.html Google
= about 126 May 7, 2007, about 203 Oct. 15, 2007 Broader
term: systems biology
conditional knockout:
A method by which a gene can be switched
off and on. Connectivity
Map, cMap: A collection of genome-wide
transcriptional expression data from cultured human cells treated with
bioactive small molecules and simple pattern-matching algorithms that together
enable the discovery of decisive functional connections between drugs, genes
and diseases through the transitory feature of common gene expression changes.
Broad Institute, MIT, Connectivity Map http://www.broad.mit.edu/cmap/ Cre-lox:
Tissue- specific gene
deletion. A
bacteriophage- derived, site- specific recombinase called Cre is used to
selectively introduce a deletion into a particular cellular compartment. The
method basically involves introducing loxP target sequences into the gene to be
deleted, and engineering expression of the Cre recombinase enzyme under the
control of a tissue- specific promoter. Thus, the enzyme is expressed only in
the desired tissue, and it deletes the gene of interest via the loxP target
sites.)
display
technologies:
We will be covering a range of display methods that are being
used to create diverse repertoires of functionally diverse biopharmaceuticals.
New classes of compounds and synthetic biologics are being translated by
display to a biologically active drug. There are a number of success stories
where display methodologies have been used to generate drug candidates that
are currently in the clinic.
See also antibody
display, cDNA
display, phage display, peptide display, ribosome display
DNA shuffling:
The use of DNA
recombination (
RECOMBINATION, GENETIC) to prepare a large gene library of novel, chimeric
genes from a population of randomly fragmented DNA
from related gene sequences. [MeSH 2003]
A method for in
vitro homologous recombination of pools of selected mutant genes by random
fragmentation and polymerase chain reaction (PCR) reassembly. Computer
simulations called genetic algorithms have demonstrated the importance of
iterative homologous recombination for sequence evolution. WP Stemmer, Rapid
evolution of a protein in vitro by DNA shuffling, Nature. 1994 Aug 4;370
(6488): 389- 391.
Google = about 4,050
Aug. 20, 2003; about 10,100 Nov. 29, 2004; about 91,800 Nov 13, 2007
Related/equivalent?
term: gene shuffling. Related terms: domain shuffling, exon shuffling, protein
shuffling
domain shuffling: Protein
structure
Google = about 862 Aug.
20, 2003; about 2,030 Nov. 29, 2004; about 25,400 Nov 13, 2006
embryonic lethal trait:
In some cases, knockout of a gene
believed to be important in a disease occurring in adult life (such as
a cancer) will be lethal to the embryo, resulting in little or no information
about the function of the gene in adult cells of interest.
Related terms knockdown, synthetic lethal screening
enucleated:
Cell from which the nucleus has been removed, used for nuclear
transfer to produce a cloned animal from differentiated cells.
Related
terms: cloning, nuclear transfer, quiescence
epigenetic,
epigenetics: Genetic
variations & SNPs epigenome, epigenomics: -Omes
& -omics
evolutionary genomics, evolutionary homology: Phylogenomics
exon shuffling theory: Contends that
introns act as spacers where breaks for genetic recombination occur. Under this
scenario, exons - which usually contain instructions for building a protein
subunit - remain intact when shuffled during recombination. In this way,
proteins with new functional repertoires can evolve. [Peter Schmidt, "Shuffling,
Recombination, and the Importance of ...Nonsense" Swarthmore
College] www.swarthmore.edu/Humanities/pschmid1/array/Gnarl3/exon.html
Related
terms: DNA shuffling, domain shuffling, gene shuffling, protein shuffling
Google "exon
shuffling" = about 2,300
Aug. 20, 2003; about 9, 150 Nov. 29, 2004
exon trapping (exon amplification):
A rapid and efficient means of finding expressed DNA sequences in a genome sequence and is based on
selection for functional splice sites in genomic DNA. The advantages of exon trapping are that it does not require any prior knowledge about
tissue- specific gene expression and can easily be performed on complex
genomes. It can identify constitutive exons as well as alternative exons
but cannot be used to identify intronless genes. [Clinical Molecular Genetics
Society UK "Exon trapping" 2000]
http://www.ich.ucl.ac.uk/cmgs/exontrap.htm
forward genetics:
The traditional approach to genetics, which starts with a
phenotype and then identifies genetic mutations or variations that control or
cause that trait. CHA, Cambridge Healthtech Advisors Model
Animal Systems: Emerging Applications and Commercial Opportunities in Drug
Discovery and Development, report, 2004
Related term: positional cloning. Compare
reverse genetics
forward genomics:
Large- scale insertional mutagenesis offers
several significant features as a genomics platform. DNA insertions allow rapid
functional analysis of phenotypes and the associated genes in a forward genomics
research program. In addition, the indexed collection of insertion mutants
creates basis for a robust program in reverse genomics by which one may
analyze phenotypes associated with any given gene identified only by sequence.
HELENA MATHEWS "Gene Discovery in Plants by Activation Tagging" In
Vitro Cell. Dev. Biol - Animal 37:3 Part II, March 2001]
functional genomics technologies: Functional
genomics
Include gene disruption, gene manipulation,
gene shuffling, gene targeting, gene trapping, knockdowns, knockins, knockouts, mutagenesis,
phage display, positional cloning, Post Translational Gene Silencing PTGS, RNA
interference RNAi. Related terms chemical
genetics, chemical genomics
gene disruption:
A key methodology in high- throughput gene functional
analysis. Involves developing various methods for randomly disrupting genes
throughout the genome of a model organism (resulting in knockouts, or null
mutations of these genes) and then determining (1) which genes have been
disrupted and (2) the phenotype (if any) of the mutant organism.
Broader term: gene manipulation
Narrower terms: knockdown, knockin, knockout, PTSG,
gene interference:
An effect similar to loss- of function mutations in
organisms, as if the gene being studied were inactivated. Both sense and
antisense RNA are already known to produce interference with the expression of
the genes they correspond to by blocking protein synthesis. Antisense RNA is
single- stranded RNA that is complementary to a particular mRNA sequence. Sense
RNA, also single- stranded, is a shorter version of a particular mRNA strand.
Another mechanism for gene interference using RNA has been developed in the past
few years. This process, called RNA interference (RNAi) involves double-
stranded RNA (dsRNA), and was first developed for use in invertebrates, later
vertebrates, and now after much doubt, has been proved to work for mammals,
specifically mice. [Dr. Bert Ely, Univ. of South Carolina, US] http://www.biol.sc.edu/~elygen/caflisch.html
Related terms gene disruption, knockout; Broader term: gene manipulation
Narrower terms: PTSG, RNAi
gene knockout:
Use of particular techniques to "knock out"
the function of a gene in a model organism. Studying the effects of the
gene knockout can help researchers understand the function of the gene that has
been inhibited.
Related terms: gene manipulation,
knockdown, knockin, knockout
gene library:
A collection of cloned DNA fragments from a variety of
species. [IUPAC Biotech]
gene manipulation:
The use of in vitro techniques to produce
DNA molecules containing novel combinations of genes or altered sequences,
and the insertion of these into vectors that can be used for their incorporation
into host organisms or cells in which they are capable of continued propagation
of the modified genes. [IUPAC Biotech]
Narrower terms: knockdowns, knockins,
knockouts, mutagenesis, biochemical genomics, exon trapping, gene
disruption, gene targeting, gene trapping; Proteomics
protein knockouts
gene shuffling:
DNA shuffling is the most powerful
molecular
evolution technique known to date, and it can be used to evolve proteins,
plasmids and viruses in vitro. We are applying this method to
improve efficacy or pharmacological properties of cytokines with
therapeutic potential.... part of the project is done in collaboration
with Maxygen (Santa Clara, CA), a biotechnology institute where the gene
shuffling technology was developed by Dr. Willem Stemmer (Stemmer, Nature
370: 389- 391, 1994; Crameri et al. Nature 391: 288, 1998). Juha
Punnonen, Role of Cytokines in Regulation of Synovial Inflammation and
Evolution of Cytokines In Vitro, Dept. of Medical Microbiology, Univ. of
Turku, Finland, 2000 http://www.utu.fi/research/tic/projects/punnonen.html Encompasses
techniques to speed up genetic evolution to screen for high value proteins.
Novel recombinant gene products are screened to identify candidate proteins
with desired activities.
Google = about 1,860 Aug. 20, 2003; about 5, 250
Nov. 29, 2004
Related terms: DNA shuffling, domain shuffling, exon shuffling, molecular evolution, protein shuffling, directed
protein evolution gene manipulation,
knockdown, knockin, knockout
gene silencing:
Interruption or suppression of the expression of a gene at transcriptional or translational levels.
MeSH, 2000
Refers to complex interactions
between DNA (transcriptional gene silencing) and RNA (post- transcriptional gene
silencing) based on the homology between these sequences, their place into the
genome, the possible modifications of their chemical structure, etc. These
interactions may stop the expression of a gene or lead to the degradation of its
transcription products (RNA), thus "silencing" the gene as no proteins
are produced anymore. Barbara Bordogna, Sustainability and Public or Private
Management Glossary, Univ. Geneva, 2003 http://supprem.unige.ch/glossary/
Narrower
terms: Post-Transcriptional Gene Silencing PTGS,
RNA silencing; Related term:
epigenetics
gene suppression: shRNA
is useful where long-term gene suppression is
required, or where the cells are resistant to other delivery methods. Its use,
however, has been limited by lack of design and processing methods that provide
reliable and reproducible gene silencing. BioIT World Weekly Update Sept 5,
2006
Broader term: gene disruption. Related term: Cancer
genomics tumor suppressor gene
gene targeting:
The integration of exogenous DNA into the
genome of an organism at sites where its
expression can be suitably controlled. This integration occurs as a result of homologous recombination.
[MeSH, 1995]
gene titration:
Dr. [Oliver] Smithies has skillfully wielded a genetic
knife - either removing or adding multiple copies of genes to mouse DNA-- to
learn more about the roles these proteins play in controlling how much and how
fast blood traverses vessels throughout the body. Such "gene
titration" experiments, as he calls them, have helped Dr. Smithies evolve a
model to describe essential hypertension, a complex disease with multiple
genetic and environmental causes. These prior studies have revealed that while
increasing the number of AGT genes in a mouse elevates blood pressure, similar
manipulations to the number of ACE genes have no effect whatsoever on a mouse's
blood pressure. Plugging such data into his customized computer program allows
Dr. Smithies to ask -- and answer -- further questions about the effects of
genetic and pharmacologic manipulations. ["Computers help decipher blood
pressure control" National Institute of General Medical Sciences research
brief, Mar. 31, 1999] http://www.nigms.nih.gov/news/releases/smithies.html
We are investigating the hypothesis that essential
hypertension, one of these diseases, is caused primarily by combinations of
quantitative genetic variants
that individually have only modest effects. To test this hypothesis we have
developed a gene targeting approach which allows the level of expression
of chosen genes to be varied systematically in different animals by varying the
number of functional copies of the target gene from 1 through 4. We have applied
this "gene titration" method to several genes in the renin-
angiotensin system and in the natriuretic peptide system and we have shown that
genetic changes which affect the level of expression of the genes coding for
angiotensinogen (AGT), or for renin, or the type 1a receptor for angiotensin II
(Atr1a), or the endothelial form of nitric oxide synthase (eNOS), or the atrial
natriuretic factor (ANF) or its receptor (NPRA) all affect blood pressures in
the mouse. [Oliver Smithies, Univ. of North Carolina- Chapel Hill, Lineberger
Comprehensive Cancer Center, 2001]
http://cancer.med.unc.edu/researchers/DisplayByList.asp?ID=178
gene trapping:
Traditional gene- trapping approaches, in which
genes are randomly disrupted with DNA elements inserted throughout the
genome, have been used to generate large numbers of mutant organisms for
genetic analysis. Recent modifications of gene- trapping methods and their
increased use in mammalian systems are likely to result in a wealth of
new information on gene function. [Durick K, et al. “Hunting with
traps” Genome Research 9(11): 1019-1025. Nov. 1999]
genetic enhancement: Genetic
& genomic testing
genetic engineering:
Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.
[MeSH, 1989]
Related term: recombinant DNA technology. [IUPAC Compendium]
genetic recombination:
Production of new arrangements of genes by various
mechanisms such as assortment and segregation, crossing over, gene conversion,
transformation, conjugation, transduction, F-duction, or mixed infection of
viruses. MeSH, 1968
Happens during the
cell division (meiosis) that occurs during the formation of sperm and egg cells.
In this process, chromosomes pair up and may swap portions of genetic material
in a phenomenon known as crossing over. The chromosomes then
reassemble and separate, with each containing some material from the other. The
chromosomes are then divvied out into individual sex cells. During crossing
over, it is more likely that far- apart genes will be separated by a break than
those that are close together. The genes that tend to stay together are said to
be linked and therefore may serve as markers for one another — a
pattern that is of particular interest when, for example, one of the genes is a
disease gene.
Related terms: recombinant, recombination
genetic vector :
Any DNA molecule capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from plasmids, bacteriophages or viruses. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain genetic markers to facilitate their selective recognition.
MeSH, 1980
genomewide knockdowns:
RNAi is already making an impact. Genomewide knockdowns have been
carried out in organisms including nematodes. Small interfering RNAs (siRNAs),
which silence genes in mammalian cells, are now being designed against as many
genes as possible. The RNA Revolution, BioIT World April 2003 http://bioitworld.com/archive/041503/blueprint_sidebar_2305.html
genomic library:
A collection of clones made from a set of randomly
generated overlapping DNA fragments representing the entire genome of an
organism. [DOE]
A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding (lacking introns).
MeSH, 1990
host:
A cell whose metabolism is used for growth and reproduction
of a virus, plasmid, or other form of foreign DNA. [IUPAC Biotech]
host-vector system:
A compatible combination of host (e.g. bacteria)
and vector (e.g. plasmid) that allows propagation of DNA. [IUPAC Biotech]
hybridoma:
A hybrid cell line resulting from the fusion of a
specific antibody- producing spleen cell (lymphocyte) with a myeloma cell,
which has the growth characteristics of the myeloma component and the antibody-
secreting
characteristics of the lymphocyte, and will multiply to become a source
of pure monoclonal antibody. [IUPAC Biotech]
Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure or "monoclonal" antibodies or T-cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent.
MeSH, 1982
insertional mutagenesis:
Mutagenesis where the mutation is caused
by the introduction of foreign DNA sequences into a gene. This process
may occur spontaneously in vivo or be experimentally induced in vivo
or in vitro. MeSH, 1991
Enables researchers to both identify and sequence
a gene, as well as get functional information about it. Is this related to gene
trapping?
Does not require knowing gene's identity or function.
Related terms: embryonic lethal,
knockdown
intrabodies:
Recent advances in antibody engineering have now allowed
the genes encoding antibodies to be manipulated so that the antigen binding
domain can be expressed intracellularly. The specific and high- affinity binding
properties of antibodies, combined with their ability to be stably expressed in
precise intracellular locations inside mammalian cells, has provided a powerful
new family of molecules for gene therapy applications. These
intracellular antibodies are termed 'intrabodies'. [Wayne A. Marasco, "Intrabodies:
turning the humoral immune system outside in for intracellular
immunization" Gene Therapy 4 (1): 11- 15, Jan. 1997]
knockdown:
Altering the function of a gene so that it can be
conditionally expressed. This is necessary when complete knockout of the
gene would be lethal to the organism.
Related terms: embryonic
lethal trait, knockin, knockout; Pharmaceutical
biology antisense; RNAI RNA
Interference
knockin: Gain of function through
addition/ substitution of genetic
material. One example of a knockin is deletion of a coding sequence of
a gene in a mouse and then replacing it with human coding sequences. Related terms:
knockdown, knockout knockout: Inactivation of specific genes. Knockouts are often
created in laboratory organisms such as yeast or mice so that scientists
can study the knockout organism as a model for a particular disease. [NHGRI]
Narrower term: conditional knockout, random homozygous
knockout Related terms gene knockout, knockdown, knockin, protein knockouts
knockout mice: Model & other
organisms Knockout-mouse
technology is considered an essential and standard technique in functional
genomics and target validation.
lambda
phage: See under bacteriophage
library: Combinatorial libraries & synthesis
How does this relate to combinatorial library and related terms in Drug
discovery & development (or more general meanings of
"library").
Narrower terms: gene library,
genomic
library; Microarrays arrayed library; Sequencing
DNA library
molecular display: See under phage display molecular evolution: The aims and scope statement of the
Journal
of Molecular Evolution states that topics addressed cover "experimental
and theoretical work aimed at deciphering features of molecular evolution
and the processes bearing on these features, from the initial formation
of macromolecular systems onward, includ[ing] the evolution
of informational macromolecules and their relation to more complex levels
of biological organization, up to populations and taxa. This coverage accommodates
well such subfields as comparative structural and
functional genomics,
population genetics, the molecular evolution of development, the evolution
of gene regulation and gene interaction networks, and in vitro evolution
of DNA and RNA. Aims and Scope, Journal of Molecular Evolution, Springer] http://www.springeronline.com/sgw/cda/frontpage/0,11855,4-10027-70-1034044-detailsPage%253D...
Wikipedia http://en.wikipedia.org/wiki/Molecular_evolution
Google = about 84,600 Aug. 20, 2003; about 440,000
Nov. 29, 2004
Narrower terms: applied molecular evolution; Proteomics
directed protein evolution Related term: gene
shuffling
molecular farming: Related/equivalent? term: pharming
Google = about 17,800 Dec. 16, 2004; about 42,500
Jan 8, 2008
molecular systems biology:
An integrative discipline that seeks to explain the properties and behaviour of
complex biological systems in terms of their molecular components and their
interactions. Nature Publishing, Molecular Systems Biology aims &
scope http://www.nature.com/msb/authors/index.html#Aims-and-scope
Broader term: systems biology
monoclonal antibodies MAbs:
Drug targets
mutagenesis: The introduction of permanent heritable changes
(i.e., mutations) into the DNA of an organism. [IUPAC Bioinorganic] Mutation
and gene disruption are powerful tools for investigating gene
function and for identifying novel genes without prior knowledge of homology
in other systems. Screening for phenotypes of interest leads to
discovery of new genes, some of the mutations becoming models
for human genetic diseases. [Functional Genomics, UK "Analysis
of phenotypic changes resulting from mutagenesis and gene disruption"
2001] http://www.functionalgenomics.org.uk/sections/programme/mutagenesis.htm Narrower
terms: chemical
mutagenesis, insertional mutagenesis, saturation mutagenesis, site- directed
mutagenesis.
Broader terms: gene disruption, gene manipulation
Related terms: knockouts, knockins, knockdowns
nuclear transfer: In
nuclear transfer the DNA is removed from an unfertilised egg and the nucleus
of a specially prepared body cell is introduced and the combination or
"couplet" is triggered either by an electrical pulse, or the
introduction of a chemical, to fuse them together and begin the process of
development. Much is still to be known about what happens in this process
and most attempts fail at the start.
At Roslin this has been achieved by inserting a treated
cell inside the outer shell of the "empty" egg. Other groups report
success in extracting the nucleus of the cell and inserting it into the egg.
Cloning & nuclear transfer: A short glossary, Mike McKeen,
Roslin Institute Online, Scotland, 1999
http://www.ri.bbsrc.ac.uk/library/research/cloning/glossary.html#clon
See also under enucleated
nucleome: -Omes & -omics null mutation:
SNPs
& Genetic variations
parthenotes:
The products of human parthenogenesis. Eggs can divide on their own as
though they had been fertilized by a sperm, then go on to develop into embryos
and offspring. Rick Weiss, Parthenotes Expand the Debate on Stem Cells,
Washington Post, Dec. 10, 2001 http://www.washingtonpost.com/ac2/wp-dyn/A18046-2001Dec9?language=printer
Related terms: Stem cells
peptide
aptamers:
Engineered protein molecules selected from
combinatorial libraries, [used] to dissect the function of specific genes and
alleles, and to trace genetic pathways. [Roger Brent "Peptide
aptamers" Molecular Sciences Institute, 1999]
Broader term: aptamers
phage:
A virus for which the natural host is a bacterial cell.
[DOE]
Used as a vector for cloning segments of DNA.
[Schlindwein]
Related terms: bacteriophage, phage display.
phage display: Functional
diversity and drug-like properties can be found from compound libraries using
display methodologies. The most favored methods are yeast and phage
display, as they offer a way to efficiently generate, screen, and optimize new
classes of drugs. PEGs
Protein Engineering Summit May 2010,Boston MA
Phage
& Yeast Display
The growth in
the monoclonal and recombinant antibodies area has been made possible by methods
to create peptide libraries by phage display and engineer properties to enable
them to become protein therapeutics. The improvements in speed and throughput
along with advances in manipulating properties such as multi-specificity,
immunogenicity, and aggregation will lead to the next generation of therapeutic
antibodies for the clinic. Phage
Display to development Therapeutic Antibodies PEGs Oct 2009 Hannover Germany
Use of genetically engineered phage to present
peptides as segments of their native surface proteins. Peptide libraries may be produced by populations
of phage with different gene sequences. IUPAC Combinatorial Chemistry
Broader
term: display technologies Related terms:
bacteriophage, biopanning, phage; Labels, signaling & detection; Proteomics directed protein evolution
pharming: Use of transgenic animals to produce
drugs in their milk, urine or eggs. Transgenic plants can also be used.
(Tobacco is said to be particularly amenable to this application).
Google = about 10,600
Sept. 19, 2002; about 11,100 Sept. 16, 2004
Related terms: Genomics crop
genomics;
Assays
& screening phenotypic screening
plasmid, plasmids:
Extrachromosomal genetic element consisting
generally of circular double- stranded DNA, which can replicate independently
of chromosomal DNA. Used as vectors for cloning DNA
in bacteria or yeast host cells. [IUPAC Bioinorganic].
Autonomously replicating, extrachromosomal circular DNA molecules, distinct
from the normal bacterial genome and nonessential for cell survival under
nonselective conditions. Some plasmids are capable of integrating into
the host genome. A number of artificially constructed plasmids are used
as cloning vectors. [DOE]
Any extrachromosomal hereditary determinant. Plasmids are
self- replicating circular molecules of DNA that are found in a variety of bacterial, archaeal, fungal, algal, and plant species.
MeSH, 1978
polyclonal antibodies:
A mixed population of antibodies that
recognize numerous epitopes. HIV Plus 9, June- July 2000 http://www.aidsinfonyc.org/hivplus/issue9/report/glossary.html
Post-Transcriptional Gene Silencing PTGS:
Was initially considered a bizarre phenomenon
limited to petunias and a few other plant species, is now one of the hottest
topics in molecular biology (1).
In the last few years, it has become clear that PTGS occurs in both plants and
animals and has roles in viral defense and transposon silencing mechanisms.
Perhaps most exciting, however, is the emerging use of PTGS and, in particular,
RNA interference (RNAi) — PTGS initiated by the introduction of
double-stranded RNA (dsRNA) — as a tool to knock out expression of specific
genes in a variety of organisms (reviewed in 1-3).
Ambion, RNA Interference and Gene Silencing, 2002 http://www.ambion.com/techlib/hottopics/rnai/
Narrower
term RNAi; Broader term: gene silencing
process biology:
protein knockouts:
Our proteomics efforts are focused largely on developing new techniques to probe
protein- protein interactions and to construct devices that allow one to monitor the levels and
post- translational modification states of hundreds or even thousands of proteins simultaneously. A third
major goal is to develop “protein knockout” methods that would allow researchers to rapidly develop
reagents to block one or more functions of a newly discovered protein to facilitate studies of its role in cellular metabolism.
[Thomas J. Kodadek, Internal Medicine and Molecular Biology, Univ. of Texas
Southwestern Graduate Biomedical School, 2001] http://www2.utsouthwestern.edu/gradschool/webrib/kodadek.htm
Google = about 24 Sept. 18, 2002;
about 89 Nov. 29, 2004; about 179 Nov. 10, 2006; about 253 June 18, 2007
protein
shuffling: We also constructed a
computational method to determine the locations of crossovers that lead to
functional hybrid proteins during in vitro recombination. Borrowing a
concept from the schema theory of genetic algorithms, our approach assumes that
crossovers resulting in functional proteins are those that least disrupt
structural integrity. ... This method can be used to predict sites for protein
shuffling and to screen sequence databases to determine optimal sets of starting
sequences for in vitro evolution by recombination. Stephen L. Mayo,
Computational Protein Design, Cal Tech, Howard Hughes Medical Institute http://www.hhmi.org/research/investigators/mayo.html
Google = about 16 Sept.
8, 2003; about 30 Nov. 29, 2004; about 115 Nov. 10, 2006
quiescence: This is the state in which all but the most
basic functions of a cell or group of cells has stopped. This is usually a
response to an unfavourable environment, such as one in which the food
supply is low or absent. The cell becomes dormant until its surroundings are
more favourable. In this state the genes that define the specialist function
of a cell "switch off" making the cell suitable for nuclear
transfer. Cloning & nuclear transfer: A short glossary,
Mike McKeen, Roslin Institute Online, Scotland, 1999
http://www.ri.bbsrc.ac.uk/library/research/cloning/glossary.html#clon
Related terms: cloning, enucleated, nuclear transfer
rDNA: See recombinant DNA
random homozygous knockout:
A genetic approach to identify genes whose
inactivation leads to loss of a particular cell function, this provides a
practical way to identify and map genes throughout the genome based on their
biological actions and roles in human diseases. The single step of gene
discovery and function validation allows rapid identification of genes and their
genetic pathways relevant to human diseases and determination of their
potentials as therapeutic targets. Dr. Limin Li "Random homozygous
knockout"
recombinant antibodies: Drug
targets
recombinant DNA, rDNA:
Biologically active DNA which has been formed
by the in vitro joining of segments of DNA from different
sources. It includes the recombination joint or edge of a heteroduplex
region where two recombining DNA molecules are connected. MeSH, 1977
recombinant DNA technology: A body of techniques for cutting apart and splicing together different pieces of
DNA. When segments of foreign DNA are transferred into another cell or organism, the substance for which they code may be produced along with substances coded for by the native genetic material of the cell or organism. Thus, these cells become "factories" for the production of the
protein coded for by the inserted DNA. NIGMS
Related terms:
biotechnology, genetic
engineering; Cell biology clones, homologous
recombination, vectors
recombinant proteins: Proteins prepared by recombinant
DNA technology. MeSH, 1986
Related term:
genetic recombination
recombinant therapeutics: See recombinant
antibodies, recombinant proteins
recombination: The formation of
new combinations and arrangements of genes during meiosis; recombination
is achieved by crossing over, independent assortment, and segregation. NHLBI
Can be natural or synthetic.
Narrower term: genetic recombination
restriction endonucleases: Stuart Linn and Werner Arber [52] and
Matthew Meselson and Robert Yuan [53] found specific restriction
endonucleases in bacteria, which act when the latter defend themselves against
the attack of bacteriophages; thus these enzymes restrict the
host range of the bacteriophages. Harry Smith and K. W. Wilcox [54] were
able to purify these enzymes, and Thomas Kelly and Hamilton Smith [55],
Kathleen Danna and Daniel Nathans [56] and Philip Sharp et
al. [57], determined their mode of action. These enzymes cut DNA
molecules each at a specific site. These observations made it possible to
isolate genes, to clone them and
analyze their biochemical structure in great detail. Following the
action of restriction endonucleases, there often arise so- called cohesive
ends in the DNA molecules [58], which tend to join together. By this means
it is possible for example to join together DNA from any eukaryotic organism
and that from the bacterial plasmids. Such recombinant DNA molecules were
first constructed by David Jackson et
al. [59], Peter Lobban and Armin Kaiser [60] and Stanley Cohen et
al. [61]. Cloned DNA molecules can be physically mapped,
using the cutting points of the restriction endonucleases as markers, [62]
and sequenced by means of sophisticated biochemical methods [63, 64]. Petter Portin in "The Origin, Development and Present Status of the
Concept of the Gene: A Short Historical Account of he Discoveries"
Univ. of Turku, Finland, 2000 http://www.bentham.org/cg/sample/cg1-1/Portin.pdf
reverse
chemical
proteomics: Chemistry & Biology
reverse genetics:
Going from a gene (or its DNA sequence), often
discovered via high- throughput sequencing and
bioinformatics technologies,
to its biological function. Reverse genetic methods are much more amenable
to whole genome, high- throughput analysis and to automation than is forward
genetics. Contrast with forward genetics, in which one goes from
a heritable phenotype to discovery of a gene and its function.
Related term:
positional cloning
reverse genomics: A genetic approach that has
proved useful in discovering and characterizing mammalian genes that regulate
cell proliferation and suppress tumorigenesis. In reverse genomics, scientists
use "reporter genes," whose expression is controlled by DNA sequences
linked to them, to investigate genetic regulatory mechanisms in both simple and
higher organisms. Researchers can now directly isolate genes that specify
functions of particular interest using reporter- gene- containing cassettes that
can manipulate, as well as monitor, the expression of genes in mammalian
chromosomes. [Stanley N. Cohen, Stanford Univ. "Manipulative Reporter Genes
and "Reverse Genomics" Joshua Lederberg Distinguished Lecture in
Molecular Genetics, Rockefeller Univ. Oct. 27, 2000] http://www.rockefeller.edu/lectures/cohen102700.html
ribosome display:
RNAi RNA interference:
A
gene silencing phenomenon whereby specific dsRNAs (
RNA, DOUBLE- STRANDED) trigger the degradation of homologous mRNA (
RNA, MESSENGER). The specific dsRNAs are processed into SMALL
INTERFERING RNA (siRNA) which serves as a guide for cleavage of the
homologous mRNA in the RNA- INDUCED SILENCING COMPLEX (RISC). DNA METHYLATION may
also be triggered during this process. MeSH 2003 See
also RNA
Narrower terms: miRNA,
siRNA
Broader terms: gene expression regulation, gene silencing
Nature Reviews
Focus on RNAi http://www.nature.com/focus/rnai/
RNAi
Consortium: A public-private consortium based at the Broad will
develop and validate tools and methods that will enable the worldwide scientific
community to use RNAi to unveil the function of most human and mouse genes. The
goal of the RNAi Consortium (abbreviated TRC) is to use the recently discovered
RNAi mechanism to create widely applicable research reagents consisting of
specific inhibitors against human and mouse genes.
http://www.broad.mit.edu/genome_bio/trc/
RNAi
therapeutics: RNAi
for therapeutic indications, June 2009, San Francisco CA
RNA silencing:
Although initially recognized as a handy tool to reduce gene expression, RNA
silencing, triggered by double- stranded RNA molecules, is now recognized as a
mechanism for cellular protection and cleansing: It defends the genome against
molecular parasites such as viruses and transposons, while removing abundant but
aberrant nonfunctional messenger RNAs. The underlying mechanisms in distinct
gene silencing phenomena in different genetic systems, such as cosuppression in
plants and RNAi in animals, are very similar. There are common RNA
intermediates, and similar genes are required in RNA silencing pathways in
protozoa, plants, fungi, and animals, thus indicating an ancient pathway.
Tijsterman M. et. al., The
genetics of RNA silencing, Annual Reviews Genetics; 36: 489- 519, 2002
Related term: RNAi RNA interference
SELEX Systematic Evolution of Ligands by Exponential Enrichment:
Process for identifying aptamers by iterative enrichment of oligonucleotide
mixtures with respect to their ability to bind a target. [IUPAC COMBINATORIAL
CHEMISTRY
saturation mutagenesis:
A technique to mutate all bases of a
gene. [Glick]
second- site mutations:
Are not lethal themselves, but in combination
with the primary defect cause lethality.
Related term:
synthetic lethal screening
shuffling: Narrower
terms: DNA shuffling, domain shuffling, exon shuffling, gene shuffling, protein
shuffling
semantic
systems biology: Semantic technologies are playing an increasingly
important role in capturing and modeling biological knowledge. Semantic
systems biology can complement the bottom-up approach with data-driven
generation of hypotheses. Therefore, Semantic Systems Biology (SSB)
is a systems biology approach that uses semantic description of knowledge
about biological systems to facilitate integrated data analysis. About
Semantic Systems Biology http://www.semantic-systems-biology.org/about
site-directed mutagenesis:
The substitution or modification of
a single amino acid at a defined location in a protein is performed by
changing one or more base pairs in the DNA using recombinant DNA technology.
[IUPAC Bioinorganic]
Mutagenesis where the mutation is caused by in vitro induction directed
at a specific site in a DNA molecule. The most common method involves use
of a chemically synthesized oligonucleotide mutant which can hybridize
with the DNA target molecule. The resulting mismatch - carrying DNA duplex
may then be transfected into a bacterial cell line and the mutant strands
recovered. MeSH, 1991
somatic cell hybridization: In somatic cell hybridization,
human cells and rodent tumor cells are fused (hybridized); over time, after
the chromosomes mix, human chromosomes are preferentially lost from the
hybrid cell until only one or a few remain. Those individual hybrid cells
are then propagated and maintained as cell lines containing specific human
chromosomes. Improvements to this technique have generated a number of
hybrid cell lines, each with a specific single human chromosome. Primer
in Molecular Genetics, Oak Ridge National Lab, US http://www.ornl.gov/hgmis/publicat/primer/intro.html
synthetic lethal screening:
Second- site mutations that are not lethal
themselves, but in combination with the primary defect cause lethality. Used in yeast
genetics, but can be generalized to model
organisms other than yeast. The rationale is that many mutations
commonly found in tumors that result in instability of the genome are loss-
of- function mutations, and it is difficult to replace the function of
missing or altered proteins with a small- molecule drug. The idea of
screening for second- site mutations is to identify targets that
when inhibited by a specific novel drug may specifically result in the death of
cells that have such a loss- of- function mutation, but that will be nontoxic to
normal cells.
systems biology: This
report focuses on the current and future applications of Systems Biology in drug
discovery, specifically in pinpointing optimal individual targets, and
combinations of targets, to overcome metabolic pathway redundancies, leading to
efficacious and safe products. Insight Pharma
Reports, Systems
biology: A disruptive technology, 2008
The label
“systems biology” is pretty awful, except, of course, for the many
even worse labels that have been tried. More important is what SB seeks to
do: transform biology and health care into a rigorous, predictive science
offering a richer understanding of biology and a vastly improved approach
to drug development and medicine. SB would build on the molecular biology
revolution and elucidate the wiring diagrams (and their rules) buried in
the data. John Russell, BioIT World, Sept 2007 http://www.bio-itworld.com/issues/2007/sept/cover-story/
Systems
biology is frequently defined as the study of all of the elements in a
biological system and their relationship to one another in response to
perturbation. Advances in science and technology are enabling the
development of this emerging and cross-disciplinary field by allowing
researchers to explore how biological components function as a network in
cells, tissues and organisms. Recently, pharmaceutical companies have
begun to embrace systems approaches in an effort to better understand
physiology, pathogenic processes and pharmacological responses. This
review focuses on recent advances within three core areas of systems
biology: data collection, data analysis, and the integration and sharing
of data. Susie
Stevens and J. Rung, Advances in systems biology: measurement, modeling
and representation, Current Opinion in Drug Discovery and Development,
2006 Mar; 9(2): 240- 250.
Systems biology is the
study of an organism, viewed as an integrated and interacting network
of genes, proteins and biochemical reactions which give rise to life. Instead of
analyzing individual components or aspects of the organism, such as sugar
metabolism or a cell nucleus, systems biologists focus on all the components and
the interactions among them, all as part of one system. These interactions are
ultimately responsible for an organism´s form and functions. Systems Biology,
the 21st century science, Institute for Systems Biology, Seattle, 2005 http://www.systemsbiology.org/Intro_to_ISB_and_Systems_Biology/Systems_Biology_--_the_21st_Century_Science
There are two opinions on what systems biology
is supposed to be. One group sees systems biology as another level of
combining data from different levels (like DNA, RNA and
protein level) (see [Leroy] HOOD). Another group wants to combine classical molecular
and cell biology with systems theory and focus on the new forms of behavior that
emerge when systems of genes and proteins are studied in a wholistic way. For
this they need data from all those different levels as well, of course. That is
why they see systems biology as a cooperative effort, with systems theory
providing a theoretical framework and a new view on things for biologists, along
with lots of experience with complex systems, and biology providing in-depth
knowledge of the field of application as well as practical handling experience.
This data is the basis for developing the kind of detailed models
that are necessary for such studies of systemic properties and behavior. For
both groups, the goal is to reach a new level of understanding of biological
systems often referred to as 'systems level' understanding. A glossary for
Systems Biology, Systems Biology Group, Stuttgart http://www.sysbio.de/projects/glossary/SYSTEMS_BIOLOGY.shtml#systems_biology
The very nature of systems biology requires integrating data from a
variety of sources generated and interpreted by people skilled in different
areas -- engineering, computer science, biology, physics, mathematics, and
statistics. Key considerations in this process include the generation of
quantitative data, barriers in communication across departments, and
organizational challenges.
Glossary for systems biology, Institutes for
System Dynamics and Control and for Systems Theory in Engineering of the
University of Stuttgart 100 + definitions, 2002 http://www.sysbio.de/projects/glossary/index.shtml
What is systems
biology? Institute for Systems Biology,
Seattle WA http://www.systemsbiology.org/Default.aspx?pagename=whatissystemsbiology
Google = about 865,000
May 25, 2005; about 1,530,000 Nov 10, 2006
Related terms: In
silico & molecular modeling; Molecular
Medicine: preventive medicine Narrower terms: comparative
systems biology, molecular
systems biology; hepatocyte
systems biology, semantic systems biology ; In
silico & molecular modeling applied systems biology, in silico biology ;
Metabolic engineering
signal transduction
Pharmaceutical
biology integrative biology-
systems biology
targeted mutation: A type of mutation
in which a chromosomal gene
is altered by the substitution of a DNA
construct assembled in
vitro. In mouse, the constructs are usually designed to eliminate gene
function; such targeted mutations are often casually referred to as knock-outs.
Some DNA constructs are designed to alter gene function; such targeted mutations
are often casually referred to as knock- ins [Mouse
Genome Informatics Glossary, Jackson Laboratories, US] http://www.informatics.jax.org/userdocs/glossary.shtml#synonym
transgenic: Model
& other organisms
vector:
1. A DNA molecule (plasmid, virus, bacteriophage, artificial
or cut DNA molecule) capable of being replicated and bearing cloning sites
for the introduction of foreign DNA, used to introduce this DNA into host
cells. 2. Any organism that transmits a disease between two hosts. IUPAC
Biotechnology
An agent, such as a virus or a small piece of DNA called a plasmid,
that carries a modified or foreign gene. When used in gene therapy,
a vector delivers the desired gene to a target cell. NHGRI
The two different senses of the IUPAC definitions should be clear from
context. The organisms transmitting pathogens can be insects or small
animals. Vectors used in gene therapy are not pathogenic.
Narrower terms: BAC Bacterial Artificial Chromosome, cloning vector, genetic vector,
plasmids
Vector databases see Databases & software
directory
Yeast Artificial Chromosomes YACS: Chromosomes in which fragments
of exogenous DNA ranging in length up to several hundred kilobase pairs have
been cloned into yeast through ligation to vector sequences. These
artificial chromosomes are used extensively in molecular biology for the
construction of comprehensive genomic libraries of higher organisms. MeSH,
2002
yeast display:
See under phage display
Bibliography
RNAi Gateway, BioMedCentral, http://www.biomedcentral.com/gateways/rnai/
Systems
Biology Gateway, BioMedCentral http://www.biomedcentral.com/gateways/systemsbiology/
Alpha
glossary index
How
to look for other unfamiliar terms
IUPAC definitions are reprinted with the
permission of the International Union of Pure and Applied Chemistry.
|